Literature DB >> 24389645

The regulation of MDM2 oncogene and its impact on human cancers.

Yuhan Zhao1, Haiyang Yu, Wenwei Hu.   

Abstract

Tumor suppressor p53 plays a central role in preventing tumor formation. The levels and activity of p53 is under tight regulation to ensure its proper function. Murine double minute 2 (MDM2), a p53 target gene, is an E3 ubiquitin ligase. MDM2 is a key negative regulator of p53 protein, and forms an auto-regulatory feedback loop with p53. MDM2 is an oncogene with both p53-dependent and p53-independent oncogenic activities, and often has increased expression levels in a variety of human cancers. MDM2 is highly regulated; the levels and function of MDM2 are regulated at the transcriptional, translational and post-translational levels. This review provides an overview of the regulation of MDM2. Dysregulation of MDM2 impacts significantly upon the p53 functions, and in turn the tumorigenesis. Considering the key role that MDM2 plays in human cancers, a better understanding of the regulation of MDM2 will help us to develop novel and more effective cancer therapeutic strategies to target MDM2 and activate p53 in cells.

Entities:  

Keywords:  E3 ubiquitin ligase; MDM2; gene regulation; p53

Mesh:

Substances:

Year:  2014        PMID: 24389645      PMCID: PMC3932834          DOI: 10.1093/abbs/gmt147

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  119 in total

1.  Identification of a cryptic nucleolar-localization signal in MDM2.

Authors:  M A Lohrum; M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

Review 2.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

3.  Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.

Authors:  J Lukas; D Q Gao; M Keshmeshian; W H Wen; D Tsao-Wei; S Rosenberg; M F Press
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

4.  The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.

Authors:  Andrew Slack; Zaowen Chen; Roberto Tonelli; Martin Pule; Lisa Hunt; Andrea Pession; Jason M Shohet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-11       Impact factor: 11.205

5.  Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26.

Authors:  Yaara Ofir-Rosenfeld; Kristy Boggs; Dan Michael; Michael B Kastan; Moshe Oren
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

6.  Depression and functional status as predictors of death among cancer patients.

Authors:  Manfred Stommel; Barbara A Given; Charles W Given
Journal:  Cancer       Date:  2002-05-15       Impact factor: 6.860

Review 7.  Do stress-related psychosocial factors contribute to cancer incidence and survival?

Authors:  Yoichi Chida; Mark Hamer; Jane Wardle; Andrew Steptoe
Journal:  Nat Clin Pract Oncol       Date:  2008-05-20

8.  MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation.

Authors:  Wei Fu; Qiuping Ma; Lei Chen; Pengfei Li; Mu Zhang; Sivapriya Ramamoorthy; Zafar Nawaz; Tsukasa Shimojima; Hengbin Wang; Yonghua Yang; Zheng Shen; Yingtao Zhang; Xiaohong Zhang; Santo V Nicosia; Yanping Zhang; Jack W Pledger; Jiandong Chen; Wenlong Bai
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

Review 9.  The MDM2 gene amplification database.

Authors:  J Momand; D Jung; S Wilczynski; J Niland
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

10.  A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1.

Authors:  Makoto R Hara; Jeffrey J Kovacs; Erin J Whalen; Sudarshan Rajagopal; Ryan T Strachan; Wayne Grant; Aaron J Towers; Barbara Williams; Christopher M Lam; Kunhong Xiao; Sudha K Shenoy; Simon G Gregory; Seungkirl Ahn; Derek R Duckett; Robert J Lefkowitz
Journal:  Nature       Date:  2011-08-21       Impact factor: 49.962

View more
  54 in total

Review 1.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  Cansu Karakas; Cassie Wang; Fangming Deng; Hongying Huang; Dongwen Wang; Peng Lee
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

Review 2.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

3.  Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.

Authors:  Tianli He; Jiayou Guo; Hongmei Song; Hongcheng Zhu; Xiaoke Di; Hua Min; Yuandong Wang; Guangzong Chen; Wangshu Dai; Jianhua Ma; Xinchen Sun; Jianxin Ma
Journal:  Pathol Oncol Res       Date:  2017-03-24       Impact factor: 3.201

4.  The MDM2 inducible promoter folds into four-tetrad antiparallel G-quadruplexes targetable to fight malignant liposarcoma.

Authors:  Sara Lago; Matteo Nadai; Emanuela Ruggiero; Martina Tassinari; Maja Marušič; Beatrice Tosoni; Ilaria Frasson; Filippo M Cernilogar; Valentina Pirota; Filippo Doria; Janez Plavec; Gunnar Schotta; Sara N Richter
Journal:  Nucleic Acids Res       Date:  2021-01-25       Impact factor: 16.971

5.  Orai3 calcium channel and resistance to chemotherapy in breast cancer cells: the p53 connection.

Authors:  Jessy Hasna; Frédéric Hague; Lise Rodat-Despoix; Dirk Geerts; Catherine Leroy; David Tulasne; Halima Ouadid-Ahidouch; Philippe Kischel
Journal:  Cell Death Differ       Date:  2018-01-11       Impact factor: 15.828

6.  Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate.

Authors:  Shumei Kato; Aaron Goodman; Vighnesh Walavalkar; Donald A Barkauskas; Andrew Sharabi; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2017-03-28       Impact factor: 12.531

7.  Serum anti-MDM2 and anti-c-Myc autoantibodies as biomarkers in the early detection of lung cancer.

Authors:  Pei Li; Jian-Xiang Shi; Li-Ping Dai; Yu-Rong Chai; Hong-Fei Zhang; Mutombo Kankonde; Peggy Kankonde; Bao-Fa Yu; Jian-Ying Zhang
Journal:  Oncoimmunology       Date:  2016-04-22       Impact factor: 8.110

Review 8.  NEDD4: a promising target for cancer therapy.

Authors:  Xiantao Ye; Lixia Wang; Bingxue Shang; Zhiwei Wang; Wenyi Wei
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

Review 9.  The Roles of MDM2 and MDMX in Cancer.

Authors:  Orit Karni-Schmidt; Maria Lokshin; Carol Prives
Journal:  Annu Rev Pathol       Date:  2016-03-17       Impact factor: 23.472

10.  The proto-oncogene function of Mdm2 in bone.

Authors:  David J Olivos; Daniel S Perrien; Adam Hooker; Ying-Hua Cheng; Robyn K Fuchs; Jung Min Hong; Angela Bruzzaniti; Kristin Chun; Christine M Eischen; Melissa A Kacena; Lindsey D Mayo
Journal:  J Cell Biochem       Date:  2018-07-16       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.